• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与炎症性肠病相关的原发性硬化性胆管炎与无炎症性肠病时发生的原发性硬化性胆管炎有差异吗?一项针对66名受试者的研究。

Does primary sclerosing cholangitis occurring in association with inflammatory bowel disease differ from that occurring in the absence of inflammatory bowel disease? A study of sixty-six subjects.

作者信息

Rabinovitz M, Gavaler J S, Schade R R, Dindzans V J, Chien M C, Van Thiel D H

机构信息

Division of Gastroenterology, University of Pittsburgh, School of Medicine, Pennsylvania 15261.

出版信息

Hepatology. 1990 Jan;11(1):7-11. doi: 10.1002/hep.1840110103.

DOI:10.1002/hep.1840110103
PMID:2295474
Abstract

Primary sclerosing cholangitis often occurs in association with inflammatory bowel disease, particularly ulcerative colitis but also Crohn's disease of the colon either with or without terminal ileal disease. Little data exist as to the effect of inflammatory bowel disease on the presenting symptoms, radiological features, response to liver transplantation, and potential risk of bile duct carcinoma in individuals with primary sclerosing cholangitis. In an effort to answer these questions, 66 patients with primary sclerosing cholangitis were studied. The definitive diagnosis of primary sclerosing cholangitis in each was accomplished using cholangiography, which in each case demonstrated characteristic beading, ectasia and stricturing of the intrahepatic and extrahepatic bile ducts. Inflammatory bowel disease was present in 47 (71.2%) patients. Thirty nine (59.1%) had ulcerative colitis; their mean age was 42.5 +/- 11.6 yr (mean +/- SD), and the male/female ratio was 2.9:1. In addition, eight patients (12.1%) had Crohn's colitis; their mean age was 40.5 +/- 6.5 yr, and the male/female ratio of this group was 1:1. Nineteen patients (28.8%) had primary sclerosing cholangitis without any inflammatory bowel disease; their mean age was 42.0 +/- 12.1 yr, and the male/female ratio in this group was 0.72:1. Seventy-two percent of the patients without inflammatory bowel disease had either jaundice, pruritus or fatigue at presentation compared with 41% of the patients with inflammatory bowel disease (p less than 0.05). In contrast, abnormal liver function tests were more common as the first manifestation of liver disease in the latter group (38% vs. 11%; p less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

原发性硬化性胆管炎常与炎症性肠病相关,尤其是溃疡性结肠炎,也可与结肠克罗恩病相关,无论是否伴有末段回肠病变。关于炎症性肠病对原发性硬化性胆管炎患者的症状表现、放射学特征、肝移植反应及胆管癌潜在风险的影响,相关数据较少。为回答这些问题,对66例原发性硬化性胆管炎患者进行了研究。通过胆管造影对每位患者进行原发性硬化性胆管炎的确诊,在每种情况下均显示肝内和肝外胆管有典型的串珠样改变、扩张及狭窄。47例(71.2%)患者存在炎症性肠病。39例(59.1%)有溃疡性结肠炎;其平均年龄为42.5±11.6岁(平均±标准差),男女比例为2.9:1。此外,8例(12.1%)有克罗恩结肠炎;其平均年龄为40.5±6.5岁,该组男女比例为1:1。19例(28.8%)患者有原发性硬化性胆管炎但无任何炎症性肠病;其平均年龄为42.0±12.1岁,该组男女比例为0.72:1。无炎症性肠病的患者中72%在就诊时出现黄疸、瘙痒或乏力,而有炎症性肠病的患者为41%(p<0.05)。相比之下,肝功能检查异常在后一组中作为肝病的首发表现更为常见(38%对11%;p<0.05)。(摘要截选至250词)

相似文献

1
Does primary sclerosing cholangitis occurring in association with inflammatory bowel disease differ from that occurring in the absence of inflammatory bowel disease? A study of sixty-six subjects.与炎症性肠病相关的原发性硬化性胆管炎与无炎症性肠病时发生的原发性硬化性胆管炎有差异吗?一项针对66名受试者的研究。
Hepatology. 1990 Jan;11(1):7-11. doi: 10.1002/hep.1840110103.
2
Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis.原发性硬化性胆管炎和自身免疫性硬化性胆管炎中慢性炎症性肠病的对比模式
EBioMedicine. 2015 Sep 2;2(10):1523-7. doi: 10.1016/j.ebiom.2015.08.041. eCollection 2015 Oct.
3
Sclerosing cholangitis in children with inflammatory bowel disease.炎症性肠病患儿的硬化性胆管炎
Aust N Z J Med. 1994 Apr;24(2):149-53. doi: 10.1111/j.1445-5994.1994.tb00550.x.
4
Characteristics and outcome of primary sclerosing cholangitis associated with inflammatory bowel disease in Asian children.原发性硬化性胆管炎与亚洲儿童炎症性肠病相关的特征和结局。
Pediatr Neonatol. 2019 Aug;60(4):396-404. doi: 10.1016/j.pedneo.2018.09.007. Epub 2018 Oct 2.
5
Outcome of patients undergoing liver transplantation for primary sclerosing cholangitis.原发性硬化性胆管炎患者肝移植的结果
Dis Colon Rectum. 2003 Aug;46(8):1124-8. doi: 10.1007/s10350-004-7291-9.
6
Impact of Inflammatory Bowel Disease Subtypes on the Post-liver Transplant Outcomes of Patients with Primary Sclerosing Cholangitis.炎症性肠病亚型对原发性硬化性胆管炎患者肝移植后结局的影响。
Dig Dis Sci. 2023 Sep;68(9):3781-3800. doi: 10.1007/s10620-023-08023-y. Epub 2023 Jul 14.
7
Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.炎症性肠病和原发性硬化性胆管炎患者抗中性粒细胞抗体的临床意义
Gut. 1992 May;33(5):657-62. doi: 10.1136/gut.33.5.657.
8
Forty-six patients with primary sclerosing cholangitis: radiological bile duct changes in relationship to clinical course and concomitant inflammatory bowel disease.46例原发性硬化性胆管炎患者:胆管影像学改变与临床病程及合并炎症性肠病的关系
Hepatogastroenterology. 1988 Dec;35(6):289-94.
9
Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis.克罗恩病结肠炎和原发性硬化性胆管炎患者结直肠癌和异型增生的风险增加。
Dis Colon Rectum. 2011 Nov;54(11):1392-7. doi: 10.1097/DCR.0b013e31822bbcc1.
10
[Primary sclerosing cholangitis and inflammatory bowel disease].[原发性硬化性胆管炎与炎症性肠病]
Tidsskr Nor Laegeforen. 1990 Apr 10;110(10):1212-6.

引用本文的文献

1
Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis.结肠炎通过抑制胆汁酸合成改善胆汁淤积性肝病。
Nat Commun. 2023 Jun 6;14(1):3304. doi: 10.1038/s41467-023-38840-8.
2
Liver manifestations and complications in inflammatory bowel disease: A review.炎症性肠病的肝脏表现及并发症:综述
World J Hepatol. 2021 Dec 27;13(12):1956-1967. doi: 10.4254/wjh.v13.i12.1956.
3
Liver involvement in inflammatory bowel disease: What should the clinician know?炎症性肠病中的肝脏受累:临床医生应该了解什么?
World J Hepatol. 2021 Nov 27;13(11):1534-1551. doi: 10.4254/wjh.v13.i11.1534.
4
Primary sclerosing cholangitis and inflammatory bowel disease comorbidity: an update of the evidence.原发性硬化性胆管炎与炎症性肠病合并症:证据更新
Ann Gastroenterol. 2019 Mar-Apr;32(2):124-133. doi: 10.20524/aog.2019.0344. Epub 2019 Jan 15.
5
Specific Features of Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.炎症性肠病合并原发性硬化性胆管炎患者的特征
J Clin Med Res. 2019 Feb;11(2):81-88. doi: 10.14740/jocmr3680. Epub 2019 Jan 5.
6
Inflammatory bowel disease in liver transplanted patients.肝移植患者中的炎症性肠病
World J Gastroenterol. 2017 May 14;23(18):3214-3227. doi: 10.3748/wjg.v23.i18.3214.
7
Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features.炎症性肠病和原发性硬化性胆管炎:表型及相关特征的综述。
Gut Liver. 2018 Jan 15;12(1):17-29. doi: 10.5009/gnl16510.
8
Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.原发性硬化性胆管炎中独特的炎症性肠病表型。
World J Gastroenterol. 2015 Feb 14;21(6):1956-71. doi: 10.3748/wjg.v21.i6.1956.
9
Hepatobiliary manifestations of ulcerative colitis: an example of gut-liver crosstalk.溃疡性结肠炎的肝胆表现:肠道-肝脏相互作用的一个范例。
Gastroenterol Rep (Oxf). 2014 Aug;2(3):193-200. doi: 10.1093/gastro/gou036. Epub 2014 Jun 20.
10
Update on inflammatory bowel disease in patients with primary sclerosing cholangitis.原发性硬化性胆管炎患者炎症性肠病的最新情况
World J Hepatol. 2014 Apr 27;6(4):178-87. doi: 10.4254/wjh.v6.i4.178.